Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.
Katz HI, Lindholm JS, Weiss JS, Shavin JS, Morman M, Bressinck R, Cornell R, Pariser DM, Pariser RJ, Weng W, et al. Katz HI, et al. Among authors: pariser rj, pariser dm. Clin Ther. 1995 May-Jun;17(3):390-401. doi: 10.1016/0149-2918(95)80104-9. Clin Ther. 1995. PMID: 7585843 Clinical Trial.
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.
Drake L, Babel D, Stewart DM, Rich P, Ling MR, Breneman D, Scher RK, Martin AG, Pariser DM, Pariser RJ, Ellis CN, Kang S, Katz HI, McDonald CJ, Muglia J, Savin RC, Webster G, Elewski BE, Leyden JJ, Bucko AD, Tschen EH, Hanifin JM, Morman MR, Shupack JL, Greer DL, et al. Drake L, et al. Among authors: pariser rj, pariser dm. J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S87-94. doi: 10.1016/s0190-9622(98)70491-8. J Am Acad Dermatol. 1998. PMID: 9631990 Clinical Trial.
Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail.
Savin RC, Drake L, Babel D, Stewart DM, Rich P, Ling MR, Breneman D, Scher RK, Martin AG, Pariser DM, Pariser RJ, Ellis CN, Kang S, Friedman D, Katz HI, McDonald CJ, Muglia J, Webster G, Elewski BE, Leyden JJ, Bucko AD, Tschen EH, Hanifin JM, Morman MR, Hilbert J, et al. Savin RC, et al. Among authors: pariser rj, pariser dm. J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S110-6. doi: 10.1016/s0190-9622(98)70494-3. J Am Acad Dermatol. 1998. PMID: 9631993 Clinical Trial.
A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.
Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski DJ, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J. Strauss JS, et al. Among authors: pariser rj, pariser dm. J Am Acad Dermatol. 2001 Aug;45(2):187-95. doi: 10.1067/mjd.2001.115965. J Am Acad Dermatol. 2001. PMID: 11464179 Clinical Trial.
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.
Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski DJ, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J. Strauss JS, et al. Among authors: pariser rj, pariser dm. J Am Acad Dermatol. 2001 Aug;45(2):196-207. doi: 10.1067/mjd.2001.115966. J Am Acad Dermatol. 2001. PMID: 11464180 Clinical Trial.
271 results